Bluefin Biomedicine
Beverly, United States · Founded 2016 · $101.0M raised
- Headquarters
- Beverly, Massachusetts
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- bluefinbiomed.com
- Total Funding
- $101.0M
- Last Round
- $101.0M Series BJan 2021
- Rounds
- 2
About
Clinical-stage biotechnology company advancing first-in-class antibody medicines targeting cancer antigens and immune-mediated diseases.
Summary
Bluefin Biomedicine is a Biotech company based in Beverly, United States, founded in 2016. It has raised $101.0M in total across 2 rounds, most recently a $101.0M Series B round in Jan 2021. Investors include Deerfield Management.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...